688105 Nanjing Vazyme Biotech

Watchlist

Market Closed Nov 15 15:00 CST

9.91BMarket Cap419.83P/E (TTM)

Nanjing Vazyme Biotech Stock Analyst Ratings & Price Target

Updated: Nov 16, 2024

Based on 12 analysts giving stock ratings to Nanjing Vazyme Biotech in the past 3 months

Strong Buy

Updated: Nov 16, 2024

The average Nanjing Vazyme Biotech stock price target is 24.06 with a max estimate of 27.00 and a min estimate of 22.29

Review Nanjing Vazyme Biotech earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Nov 16, 2024

Strong Buy

Updated: Nov 16, 2024

Overall

No Data